Metabolic and inflammatory parameters changes in schizophrenic patients during three months of treatment with long acting risperidone

被引：0
|
作者：
Karlovic, D. [1 ]
Solter, V. [1 ]
Potkonjak, J. [1 ]
机构：
[1] Univ Zagreb, Sestre Milosrdnice Univ Hosp, Dept Psychiat, Zagreb, Croatia
来源：
EUROPEAN PSYCHIATRY | 2007年 / 22卷
关键词：
D O I：
10.1016/j.eurpsy.2007.01.509
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S157 / S157
页数：1
相关论文
共 50 条
  • [41] Hospitalization rates decrease during long-term treatment with long-acting risperidone injection
    Chue, P
    Devos, E
    Duchesne, I
    Leal, A
    Mehnert, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S281 - S282
  • [42] Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone
    Marc De Hert
    Aurélia Mittoux
    Yuan He
    Joseph Peuskens
    European Archives of Psychiatry and Clinical Neuroscience, 2011, 261 : 231 - 239
  • [43] Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone
    De Hert, Marc
    Mittoux, Aurelia
    He, Yuan
    Peuskens, Joseph
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2011, 261 (04) : 231 - 239
  • [44] Switching schizophrenic patients from conventional depot neuroleptics to long-acting injectable risperidone reduces extrapyramidal symptoms
    Medori, R
    Schreiner, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S401 - S401
  • [45] The impact of risperidone long acting injection on the 6-12 months outcome in patients suffering from psychosis
    Gupta, R.
    Chitewe, A.
    Rochricht, E.
    Bottlender, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S412 - S412
  • [46] Assessing weight change of risperidone long - acting injectable treatment in dual diagnosis patients
    Natan, Z.
    Gimelfarb, Y.
    Kaikov, E.
    EUROPEAN PSYCHIATRY, 2008, 23 : S165 - S165
  • [47] One-year hospitalization rates in patients with schizophrenia during long-term treatment with long-acting intramuscular risperidone
    Chue, P
    Devos, E
    Duchesne, I
    Leal, A
    Mehnert, A
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 277 - 278
  • [48] Treatment effectiveness and adherence in patients with schizophrenia treated with risperidone long-acting injection
    Chang, Chen-Lin
    Tzeng, Dong-Sheng
    Lung, For-Wey
    PSYCHIATRY RESEARCH, 2010, 180 (01) : 16 - 19
  • [49] Long-acting risperidone in schizophrenic patients compared with oral olanzapine and haloperidol decanoate:: A cost-effectiveness analysis
    Llorca, PM
    Mosqueda, JGJ
    Miadi-Fargier, H
    Durand-Zaleski, I
    Lançon, C
    Casadebaig, F
    Philippe, A
    Guillon, P
    Mehnert, A
    Chicoye, A
    VALUE IN HEALTH, 2002, 5 (06) : 456 - 456
  • [50] Response, remission and relapse during the long-term treatment of schizophrenia patients with long-acting injectable risperidone versus olanzapine
    Potapov, A.
    Eduard, T.
    Sergey, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 158 - 158
12345